The Pharmacy Times® Eye Care Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of eye diseases and conditions, including age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma.
April 10th 2024
In a review, investigators focused on ranibizumab (Lucentis; Genentech), aflibercept (Eylea; Regeneron), and bevacizumab (Avastin; Genentech) as growth opportunities in the biosimilar space.
Addressing Unmet Needs and Treatment Gaps in the Clinical Management of Neovascular Age-Related Macular Degeneration: Practical Strategies for Pharmacists in Specialty and Man...
1.5 Credits / Ophthalmology/Optometry
View More
Management of Neuromyelitis Optica Spectrum Disorder: Expert Insights and Updates for Pharmacists, featuring a Patient Perspective
1.5 Credits / Ophthalmology/Optometry
View More
The Promising Role of Novel Targeted Therapies in Addressing Clinical and Economic Burdens in Diabetic Macular Edema
1.5 Credits / Ophthalmology/Optometry
View More
Geographic Atrophy: The Role of the Specialty Pharmacist in Introducing Disease-Specific Therapies
1.5 Credits / Ophthalmology/Optometry
View More
Improving Outcomes and Quality of Care in Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care
3.0 Credits / Ophthalmology/Optometry
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
AMD and DME: Addressing the Disease Burden, Treatment Challenges, and Opportunities for Improved Management
1.0 Credit / Ophthalmology/Optometry
View More
AMD and DME: Exploring New and Emerging Therapies in the Treatment Landscape
1.0 Credit / Ophthalmology/Optometry
View More
AMD and DME: Highlighting the Role of the Pharmacist in Patient Education and Counseling
1.0 Credit / Ophthalmology/Optometry
View More
Maximizing Patient Outcomes in Ophthalmologic Diseases: How Managed Care Professionals Play a Key Role in Facilitating Uptake of Biosimilars
1.0 Credit / Ophthalmology/Optometry
View More
Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Prevention (Pharmacist Credit)
2.0 Credits / Ophthalmology/Optometry
View More
Addressing Unmet Needs in Dry Eye Disease: The Role of the Pharmacist in the Treatment, Management, and Prevention (Pharmacy Technician Credit)
2.0 Credits / Ophthalmology/Optometry
View More
Assessing Utility of Anti-Vascular Endothelial Growth Factor Therapies in Retinal Disease: The Pharmacist’s Role From Access to Adherence, featuring a Patient Perspective
1.5 Credits / Ophthalmology/Optometry
View More
The Evolving Treatment Paradigm of Demodex Blepharitis: Considerations for Pharmacists (Pharmacy Technician Credit)
1.0 Credits / Ophthalmology/Optometry, Dermatology
View More
The Evolving Treatment Paradigm of Demodex Blepharitis: Considerations for Pharmacists (Pharmacist Credit)
1.0 Credits / Ophthalmology/Optometry, Dermatology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy
Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Read More
According to Ocular Therapeutix, Dextenza is now the first FDA-approved, physician-administered intracanalicular insert capable of delivering a preservative-free drug for the treatment of ocular itching associated with allergic conjunctivitis with a single administration for up to 30 days.
Read More
FDA Approves First Ophthalmology Biosimilar for Neovascular Age-Related Macular Degeneration
September 20th 2021An anti-vascular endothelial growth factor therapy, ranibizumab prevents vision loss in patients with retinal vascular disorders, which can cause irreversible blindness or visual impairments in adults.
Read More
Study: Children of Mothers With Diabetes During Pregnancy Have Increased Risk of Eye Problems
September 10th 2021The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.
Read More
Topline results from the phase 2/3 XIRIUS study of cotoretigene toliparvovec (BIIB112), a gene therapy being investigated as a one-time therapy for patients with X-linked retinitis pigmentosa (XLRP), found that the study did not meet its primary endpoint of demonstrating a statistically significant improvement in the proportion of treated study eyes.
Read More